Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Sex hormone therapy and progression of cardiovascular disease in menopausal women.

Alhurani RE, Chahal CA, Ahmed AT, Mohamed EA, Miller VM.

Clin Sci (Lond). 2016 Jul 1;130(13):1065-74. doi: 10.1042/CS20160042. Review.

2.

Specific cell-derived microvesicles: Linking endothelial function to carotid artery intima-media thickness in low cardiovascular risk menopausal women.

Miller VM, Lahr BD, Bailey KR, Hodis HN, Mulvagh SL, Jayachandran M.

Atherosclerosis. 2016 Mar;246:21-8. doi: 10.1016/j.atherosclerosis.2015.12.030. Epub 2015 Dec 28.

3.

Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.

Miller VM, Jenkins GD, Biernacka JM, Heit JA, Huggins GS, Hodis HN, Budoff MJ, Lobo RA, Taylor HS, Manson JE, Black DM, Naftolin F, Harman SM, de Andrade M.

Physiol Genomics. 2016 Jan;48(1):33-41. doi: 10.1152/physiolgenomics.00029.2015. Epub 2015 Oct 27.

4.

Estrogen and Cardiovascular Disease: Is Timing Everything?

Giordano S, Hage FG, Xing D, Chen YF, Allon S, Chen C, Oparil S.

Am J Med Sci. 2015 Jul;350(1):27-35. doi: 10.1097/MAJ.0000000000000512. Review. No abstract available.

5.

Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.

Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S.

PLoS Med. 2015 Jun 2;12(6):e1001833; discussion e1001833. doi: 10.1371/journal.pmed.1001833. eCollection 2015 Jun.

6.

Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.

Miller VM, Lahr BD, Bailey KR, Heit JA, Harman SM, Jayachandran M.

Platelets. 2016;27(1):32-42. doi: 10.3109/09537104.2015.1023273. Epub 2015 Apr 9.

7.

Genetics of cardiovascular disease: Importance of sex and ethnicity.

Winham SJ, de Andrade M, Miller VM.

Atherosclerosis. 2015 Jul;241(1):219-28. doi: 10.1016/j.atherosclerosis.2015.03.021. Epub 2015 Mar 16. Review.

8.

Measurement of estradiol, estrone, and testosterone in postmenopausal human serum by isotope dilution liquid chromatography tandem mass spectrometry without derivatization.

Wooding KM, Hankin JA, Johnson CA, Chosich JD, Baek SW, Bradford AP, Murphy RC, Santoro N.

Steroids. 2015 Apr;96:89-94. doi: 10.1016/j.steroids.2015.01.007. Epub 2015 Jan 21.

9.

Impact of continuous versus discontinuous progesterone on estradiol regulation of neuron viability and sprouting after entorhinal cortex lesion in female rats.

Barron AM, Brown MA, Morgan TE, Pike CJ.

Endocrinology. 2015 Mar;156(3):1091-9. doi: 10.1210/en.2014-1216. Epub 2014 Dec 16.

10.

Sex-specific immune modulation of primary hypertension.

Sandberg K, Ji H, Hay M.

Cell Immunol. 2015 Apr;294(2):95-101. doi: 10.1016/j.cellimm.2014.12.001. Epub 2014 Dec 8. Review.

11.

Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.

Miller VM.

J Womens Health (Larchmt). 2014 Dec;23(12):997-1004. doi: 10.1089/jwh.2014.4995.

12.

Endothelial function in women of the Kronos Early Estrogen Prevention Study.

Kling JM, Lahr BA, Bailey KR, Harman SM, Miller VM, Mulvagh SL.

Climacteric. 2015 Apr;18(2):187-97. doi: 10.3109/13697137.2014.986719. Epub 2015 Feb 5.

13.

Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.

Files JA, Miller VM, Cha SS, Pruthi S.

J Womens Health (Larchmt). 2014 Oct;23(10):801-5. doi: 10.1089/jwh.2014.4871. Epub 2014 Sep 30.

14.

Yes! Sex matters: sex, the brain and blood pressure.

Hay M, Xue B, Johnson AK.

Curr Hypertens Rep. 2014 Aug;16(8):458. doi: 10.1007/s11906-014-0458-4. Review.

15.

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets.

Raz L, Hunter LW, Jayachandran M, Heit JA, Miller VM.

Physiol Rep. 2014 Mar 27;2(3):e00275. doi: 10.1002/phy2.275. Print 2014.

16.

Impact of ovarian function on cardiovascular health in women: focus on hypertension.

Maric-Bilkan C, Gilbert EL, Ryan MJ.

Int J Womens Health. 2014 Jan 24;6:131-9. doi: 10.2147/IJWH.S38084. eCollection 2014. Review.

17.

Premature menopause and risk of neurological disease: basic mechanisms and clinical implications.

Scott EL, Zhang QG, Vadlamudi RK, Brann DW.

Mol Cell Endocrinol. 2014 May 25;389(1-2):2-6. doi: 10.1016/j.mce.2014.01.013. Epub 2014 Jan 22. Review.

18.

The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition.

Wharton W, Gleason CE, Dowling NM, Carlsson CM, Brinton EA, Santoro MN, Neal-Perry G, Taylor H, Naftolin F, Lobo RA, Merriam G, Manson JE, Cedars MI, Miller VM, Black DM, Budoff M, Hodis HN, Harman SM, Asthana S.

J Alzheimers Dis. 2014;40(2):331-41. doi: 10.3233/JAD-130245.

19.

Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

Khalil RA.

Biochem Pharmacol. 2013 Dec 15;86(12):1627-42. doi: 10.1016/j.bcp.2013.09.024. Epub 2013 Oct 4.

20.

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.

Dowling NM, Gleason CE, Manson JE, Hodis HN, Miller VM, Brinton EA, Neal-Perry G, Santoro MN, Cedars M, Lobo R, Merriam GR, Wharton W, Naftolin F, Taylor H, Harman SM, Asthana S.

PLoS One. 2013 Jul 17;8(7):e68741. doi: 10.1371/journal.pone.0068741. Print 2013.

Supplemental Content

Support Center